Models

Submission ID Name Format Sort Ascending Submitter Submitted Modified Certification
DDMODEL00000121 Nathan_2008_HbA1c_prediction PharmML 0.8.x Paolo Magni 2015/12/12 2016/10/10 uncertified model
DDMODEL00000117 Friedrich_2014_LDL PharmML 0.8.x Paolo Magni 2015/12/12 2016/10/13 uncertified model
DDMODEL00000007 DelBene_2009_oncology_in_vitro PharmML 0.8.x Paolo Magni 2014/09/25 2016/10/10 uncertified model
DDMODEL00000122 Samtani_2010_Hb1Ac_prediction PharmML 0.8.x Paolo Magni 2015/12/12 2016/10/10 uncertified model
DDMODEL00000113 Russu_2009_dose_escalation_loglog PharmML 0.8.x Paolo Magni 2015/12/12 2016/10/13 uncertified model
DDMODEL00000003 Hamren_2008_diabetes_tesaglitazar PharmML 0.8.x Paolo Magni 2014/09/25 2016/10/10 uncertified model
DDMODEL00000096 Terranova_2013_oncology_TGI_combo PharmML 0.8.x Paolo Magni 2015/12/10 2016/10/10 uncertified model
DDMODEL00000118 Friedrich_2014_PK PharmML 0.8.x Paolo Magni 2015/12/12 2016/10/13 uncertified model
DDMODEL00000008 Rocchetti_2013_oncology_TGI_combo PharmML 0.8.x Paolo Magni 2014/09/26 2016/10/10 uncertified model
DDMODEL00000123 AitOudhia_2012_CRP_canakinumab PharmML 0.8.x Paolo Magni 2015/12/12 2016/10/13 uncertified model
DDMODEL00000274 Terranova_2017_oncology_TGI PharmML 0.8.x Elena Maria Tosca 2017/12/21 2017/12/22 uncertified model
DDMODEL00000114 Russu_2009_dose_escalation_Emax PharmML 0.8.x Paolo Magni 2015/12/12 2016/10/13 uncertified model
DDMODEL00000110 Magni_2000_diabetes_C-peptide PharmML 0.8.x Paolo Magni 2015/12/11 2017/11/08 uncertified model
DDMODEL00000004 DeWinter_2006_diabetes PharmML 0.8.x Paolo Magni 2014/09/25 2016/10/10 uncertified model
DDMODEL00000119 Bender_2012_thrombocytopenia_TDM1 PharmML 0.8.x Paolo Magni 2015/12/12 2016/10/13 uncertified model
DDMODEL00000124 Madrasi_2014_HIV_tenofovir PharmML 0.8.x Paolo Magni 2015/12/13 2016/10/10 uncertified model
DDMODEL00000115 Russu_2009_dose_escalation_power PharmML 0.8.x Paolo Magni 2015/12/12 2016/10/13 uncertified model
DDMODEL00000227 Glucose kinetics in humans: a unique model for different tests PharmML 0.8.x Roberto Bizzotto 2016/10/14 2017/06/30 uncertified model
DDMODEL00000111 Magni_2004_diabetes_IVGTT PharmML 0.8.x Paolo Magni 2015/12/11 2017/11/08 uncertified model
DDMODEL00000005 Lledo-Garcia_2013_diabetes PharmML 0.8.x Paolo Magni 2014/09/25 2016/10/10 uncertified model
DDMODEL00000120 Hansson_2013_hypertension_sunitinib PharmML 0.8.x Paolo Magni 2015/12/12 2016/10/10 uncertified model
DDMODEL00000233 Zierhut_2008_Population PKPD model for Fc-osteoprotegerin in healthy postmenopausal women PharmML 0.8.x Kyle Baron 2016/11/18 2018/07/13 uncertified model
DDMODEL00000116 Friedrich_2014_HDL PharmML 0.8.x Paolo Magni 2015/12/12 2016/10/13 uncertified model
DDMODEL00000112 Magni_2006_diabetes_MinimalModel PharmML 0.8.x Paolo Magni 2015/12/11 2016/10/13 uncertified model
DDMODEL00000006 Simeoni_2004_oncology_TGI PharmML 0.8.x Paolo Magni 2014/09/25 2016/10/05 certified model
DDMODEL00000102 Meibohm_2013_oncology_EMD525797_TMDD PharmML Nadia Terranova 2015/12/11 2016/07/18 uncertified model
DDMODEL00000089 Chan 2010 - HIV PKPD Viral Load Model PharmML Phylinda Chan 2015/12/10 2016/05/25 uncertified model
DDMODEL00000127 Bueno_PreclinicalBiomarkerTGI PharmML Niklas Hartung 2015/12/14 2016/07/15 uncertified model
DDMODEL00000002 Friberg_2009_Schizophrenia_Asenapine_PANSS PharmML Zinnia Parra-Guillen 2014/09/24 2016/05/18 uncertified model
DDMODEL00000213 Li_2006_PK_Meropenem_AdultPatients PharmML Lisa Ehmann 2016/08/26 2016/08/30 uncertified model
DDMODEL00000108 Chen’s exocytosis model PharmML Roberto Bizzotto 2015/12/11 2016/05/18 uncertified model
DDMODEL00000094 Insulin sensitivity from labeled IVGTT PharmML Roberto Bizzotto 2015/12/10 2016/05/18 uncertified model
DDMODEL00000195 Sibrotuzumab_PK_Carcinoma PharmML Niklas Hartung 2016/05/31 2016/07/15 uncertified model
DDMODEL00000229 A model for monoclonal antibody-based targeted therapy of Gemtuzumab Ozogamicin (GO) for acute myeloid leukemia (AML) PharmML Moran Optimata 2016/10/26 2016/11/01 uncertified model
DDMODEL00000132 Minimal model PharmML Roberto Bizzotto 2015/12/29 2016/05/18 uncertified model
DDMODEL00000103 Trefz_2015_metabolism_Kuvan_TurnoverKPD PharmML Nadia Terranova 2015/12/11 2016/07/18 uncertified model
DDMODEL00000090 Claret_2009_oncology_capecitabine_TGI PharmML Nadia Terranova 2015/12/10 2016/07/13 uncertified model
DDMODEL00000128 Ribba_2012_PCV PharmML Christian Laveille 2015/12/15 2015/12/16 uncertified model
DDMODEL00000230 A pharmacokinetic model for interleukin-21 therapy validated prospectively in murine experiments in melanoma PharmML Moran Optimata 2016/10/26 2016/11/01 uncertified model
DDMODEL00000078 Chalret_2014_Abexinostat PharmML Vincent Croixmarie 2015/12/09 2016/02/12 uncertified model
DDMODEL00000091 Van Cauter C-peptide model PharmML Roberto Bizzotto 2015/12/10 2016/05/18 uncertified model
DDMODEL00000225 PKPD model for ciprofloxacin PharmML David Khan 2016/10/13 2016/10/13 uncertified model
DDMODEL00000186 Friberg_2002_Oncology_Paclitaxel_Myelosuppression PharmML Zinnia Parra-Guillen 2016/05/17 2016/08/24 uncertified model
DDMODEL00000129 Peigne_2015_Ivabradine PharmML Vincent Croixmarie 2015/12/16 2016/02/12 uncertified model
DDMODEL00000231 PK/PD model of sunitinib in non-small cell lung cancer patients PharmML Moran Optimata 2016/10/27 2016/10/27 uncertified model
DDMODEL00000106 Krippendorff model for receptor-mediated endocytosis PharmML Zinnia Parra-Guillen 2015/12/11 2016/07/15 uncertified model
DDMODEL00000101 Overgaard’s beta cell model for insulin secretion PharmML Roberto Bizzotto 2015/12/11 2016/09/20 certified model
DDMODEL00000087 Benson 2014 - FAAH Inhibitors Systems Pharmacology Model for Pain PharmML Phylinda Chan 2015/12/10 2016/05/25 uncertified model
DDMODEL00000001 Friberg_2009_Schizophrenia_Prolactin PharmML Zinnia Parra-Guillen 2014/09/24 2016/05/24 uncertified model
DDMODEL00000212 TerHeine_2014_PK_Tamoxifen_ActiveMetabolite_CYP2D6 PharmML Lena Klopp-Schulze 2016/08/26 2016/08/30 uncertified model
Showing 1 to 50 of 151 models
First Previous 1 2 3 4 Next Last
 
Help